JPRN-UMIN000012536已完成1 期
Phase I study of Erlotinib with Cisplatin, Pemetrexed, and Bevacizumab for chemotherapy naive advanced non-squamous non small cell lung cancer harboring EGFR mutation - Quartet trial for chemo-naive advanced non-SQ NSCLC harboring EGFR mutation
Osaka Prefectural Medical Center for Respiratory and Allergic diseases0 个研究点目标入组 12 人开始时间: 2013年12月10日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Serious infections 2)Serious clinical problems 3)Interstitial pneumonia/lung fibrosis on chest CT 4)Active concomitant malignancy 5)Symptomatic brain metastasis 6)Massive pericardial, pleural effusion, ascites 7)Previous drug allergy 8)not adequated for bevacizumab 9)Those judged to be not suitable by the attending physician
研究者
相似试验
招募中
1 期
A phaseI/II study of Erlotinib/Carboplatin/Pemetrexed/Bevacizumab in chemotherapy-naive patients with EGFR mutation positive advanced non-squamous non-small-cell lung canceron-Small-Cell Lung CancerJPRN-UMIN000013202Kansai Medical University Hirakata Hospital35
招募中
1 期
A phase 1 study of cisplatin/pemetrexed/crizotinib followed by maintenance crizotinib in patients with stage 3B or 4 EML4-ALK positive non-small-cell lung cancer.Chemo-na&iumlve advanced ALK positive NSCLCJPRN-UMIN000009256ational organization Kinki-chuo chest medical center10
Unknown
2 期
Erlotinib Versus Vinorelbine/Cisplatin as Adjuvant Treatment in Stage IIIA NSCLC Patients With EGFR MutationsNon-small Cell Lung Cancer Stage IIIANCT01410214Chinese Lung Cancer Surgical Group80
进行中（未招募）
不适用
A Pilot Study of Erlotinib and Temsirolimus in Patients with Advanced Non-small Cell Lung Cancer After Failure of at Least 1 Prior Platinum-based TreatmentSCLCEUCTR2009-017101-11-ATMUW, Klinik für Innere Medizin I, Onkologie20
已完成
2 期
A Phase II Study of Erlotinib for previously treated Non-small cell Lung Cancer Patients with Epidermal Growth Factor Receptor Mutatioon-small cell lung cancerJPRN-UMIN000002716Central Japan Lung Study Group (CJLSG)29